References
- Gelinas DF. Oximetry as an early indicator of respiratory involvement in ALS. 11th Annual Symposium on ALS/NMD, Dec. 2000; ALS 2000; 1(Suppl 3): 38–39.
- Fallat RJ, Jewitt B, Bass M et al. Spirometry in ALS. Arch Neurol 1979; 36: 76–80.
- Ringel SP, Murphy JR, Alderson MD et al. The natural history of ALS. Neurology 1993; 43: 1316–1322.
- Mendoza M, Moore D, Gelinas D, Miller RA. Comparison of MIP and FVC in ALS. 11th Annual Symposium on ALS/NMD, Dec. 2000; ALS 2000; 1(Suppl 3): 39.
- Sanjak M, Salachas P, Frija-Orvoen F et al. Prospective quality control of VC as primary end point in international multicenter therapeutic trial of xaloproden in ALS. 11th Annual Symposium on ALS/NMD, Dec. 2000; ALS 2000; 1(Suppl 3): 59–60.
- Miller RG, Moore DH, Gelinas DF et al. Phase III random- ized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 2001; 56: 843–848.